Skip to main content
. Author manuscript; available in PMC: 2019 Nov 14.
Published in final edited form as: Int J Tuberc Lung Dis. 2019 Apr 1;23(4):491–497. doi: 10.5588/ijtld.18.0336

Table 2.

Patient-based predictors of MAC vs. MAC + other NTM respiratory specimens in HIV-infected subjects

MAC-positive (n = 18) % MAC + other NTM (n = 16) % P value
Age, years, mean ± SD 47 ± 8 42 ± 7 0.04
Male sex, 83 69 0.32
CD4 count, cells/mm3, median [IQR] 32 [18–83] 25 [11–106] 0.82
cART use 33 31 0.90
On MAC prophylaxis 11 25 0.39
Ever smoker 83 56 0.13
Esophageal reflux 17 6 0.60
COPD 39 31 0.64
Diabetes mellitus 6 19 0.32
Hematocrit, %, mean ± SD 35 ± 5 32 ± 6 0.12

MAC = M. avium complex; NTM = non-tuberculous mycobacteria; HIV = human immunodeficiency virus; SD = standard deviation; IQR = interquartile range; cART = combined antiretroviral therapy; COPD = chronic obstructive pulmonary disease.